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The Big Picture
Mapping SARS in Hong Kong
Epidemiologists have long used maps to track the
spread of disease, and in the past decade, geographic
information system (GIS) technology has added power-
ful new tools that help reveal far more than simply the
“where” and “when” of epidemics. Now P.C. Lai of the
University of Hong Kong and colleagues show how
GIS technology can be used during an acute infectious
disease outbreak to reveal crucial real-time, quantitative
information, such as the direction of superspreading
events (in which one person infects more than the typi-
cal three or fewer others) and distinct disease hot spots
[EHP 112:1550–1556]. Reaching beyond typical
descriptive mapping, this study demonstrates the rich
depth of GIS capabilities in analyzing patterns of dis-
ease spread from various perspectives.
The global outbreak of severe acute respiratory syn-
drome (SARS) in late 2002 and into 2003 ultimately
accounted for more than 8,000 cases in 29 countries,
according to the World Health Organization. About 20% of the cases
were in Hong Kong. Lai and colleagues applied geostatistical methods
to analyze the spread of SARS in Hong Kong during this time period. 
The investigators analyzed an integrated database that contained
clinical and personal details on the 1,755 Hong Kong patients con-
firmed to have had SARS. They plotted patient residence addresses
using a GIS to research such aspects as the superspreading event
responsible for more than 300 cases in the Amoy Gardens housing
development and microclusters of SARS cases (where the density of
infection varied widely between districts). 
The geostatistical analysis was conducted at three levels: elemen-
tary (visual inspection of geographical phenomena), cluster analysis to
identify hot spots, and contextual analysis to explain relationships
between geographical phenomena. Among the methods the
researchers applied were nearest neighbor analysis, which discerns
nonrandom distribution of cases and is often used by scientists study-
ing species distribution. For another analysis, they used the kernel
mathematical method to create a series of statistical “surfaces” to
reveal daily changes in disease hot spots.
Elementary analysis revealed the spread of the disease: a clear clus-
tering of cases in certain districts of the Kowloon peninsula, where
Amoy Gardens is located, and in Hong Kong’s New Territories region.
Next, cluster analysis produced a series of 12 kernel maps based on
date of symptom onset. These maps showed the density of SARS
patients (adjusted for underlying population density) on typical days
representing different stages of the 16-week outbreak; this demonstrat-
ed the development and dissipation of disease hot spots over the course
of events. Another sophisticated analysis produced a map that summa-
rized SARS hot spots by infection rate per 1,000 population, indicat-
ing that the urban population was at the highest risk.
With contextual analysis, the researchers developed origin-and-
destination plots for three superspreading event clusters: Prince of
Wales Hospital, Amoy Gardens, and Lower Ngau Tau Kok
Housing Estate. The Prince of Wales Hospital cluster showed a
northwest–southwest trend of disease spread that extended over most
of Hong Kong (visitors to SARS patients at Prince of Wales Hospital
spread the disease as they returned home, the authors observed). The
Amoy Gardens cluster was comparatively more localized, while the
Lower Ngau Tau Kok cluster was the most contained of the three. 
The authors cautioned of limitations in applying GIS technology
to infectious disease epidemiology and outbreak investigation, among
them the occasional lack and unavailability of the necessary data. Still,
the authors wrote, “integration of GIS technology into routine field
epidemiologic surveillance can offer a scientifically rigorous and quan-
titative method for identification of unusual disease patterns in real
time.” When linked with point-of-care databases and other sources of
environmental data (including meteorological, transportation, and
topographical information), such geospatial intelligence has the
potential to rapidly recognize, locate, and monitor disease outbreaks.
–Laura Alderson
A Hazard in Utero?
Bisphenol A More Potent than Expected
Environmental estrogens are a structurally diverse group of chemi-
cals that partially mimic the effects of endogenous estrogens.
Scientists believe the wide use of environmental estrogens such as
bisphenol A (BPA), a component of epoxy resins and polycarbon-
ate plastics, may help explain the rising incidence of birth defects
and certain cancers. It is further believed that the developing
embryo is more vulnerable to the effects of environmental estro-
gens than adult animals, but until now it has been difficult to
determine these effects directly in embryos. In this issue, Josephine
G. Lemmen of the Netherlands Institute for Developmental
Biology and colleagues investigate the use of a new transgenic
mouse model to study such effects [EHP 112:1544–1549]. 
During the late 1990s, it was first suggested that prenatal exposure
to BPA might cause reproductive abnormalities; experimental data,
however, led to contradictory findings. For instance, one 1999 study
showed prostate enlargement in offspring of BPA-exposed mice, but
other studies reported no effect. Although BPA concentrations in
amniotic fluid at 15–18 weeks’ gestation have been shown to be five
times those in the serum of pregnant and nonpregnant women—sug-
gesting possible accumulation in the embryo—this could not be con-
firmed through animal experiments.
Lemmen and her colleagues recently developed a transgenic
mouse in which estrogen-responsive elements are coupled with the
reporter enzyme luciferase. Direct activation of estrogenic receptors
(ERs) is detected photometrically by measuring luciferase activity,
which allows quantitative and time-course analysis of target gene acti-
vation in vivo. The C57Bl/6J mouse strain used in this model had
previously been shown to be especially sensitive to the effects of estro-
gen exposure. 
This model was used to evaluate the ability of BPA to activate
endogenous ERs in mouse embryos, as compared with the strong
Bird’s-eye view of SARS. Using GIS technology, researchers have mapped how SARS
spread in Hong Kong to help predict patterns of future infectious disease epidemics.Science Selections
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estrogens diethylstilbestrol (DES) and 17β-estradiol dipropionate (EP).
Exposure of pregnant mice to varying dosages of all three estrogens
activated the endogenous ERs in their embryos. Exposure to DES and
EP showed a dose- and time-dependent induction of luciferase activity.
For all DES exposures, peak activity was seen at 8 hours after exposure.
For EP, peak activity was seen at 24 hours after exposure.
Like DES, BPA showed a transient induction of luciferase activity.
Surprisingly, though, BPA was found to be more potent in vivo than
would have been expected on the basis of its activity in vitro. In utero
luciferase activation by BPA in transgenic embryos at 8 hours after
exposure was significant at a dosage as low as 1 milligram BPA per
kilogram body weight, compared with controls. 
One possible explanation for a higher potency in utero may be
that in vivo BPA is converted to metabolites with enhanced estro-
genicity, as some previous studies have suggested. Yet another expla-
nation could be that BPA has a lower affinity with steroid-binding
proteins present in serum, which gives it a greater bioavailability than,
say, EP. However, these explanations cannot account for the in vivo
versus in vitro potency of BPA as compared with DES, because nei-
ther has a high affinity to binding proteins.
Although BPA’s intrinsic activity is lower than that of DES or EP,
it still was more potent in vivo than would be estimated from in vitro
assays. Effects on individual embryonic organs have not yet been eval-
uated and could possibly provide even more sensitive end points than
whole embryos. Although the Lemmen study model showed that the
effects of BPA did not persist like those of the other estrogens, its bio-
logical effects in exposed embryos should continue to be assessed, per-
haps with other types of models. –Julian Josephson
The Safety of Xenoestrogens
Challenging the Genomic Model of Effects
Current thinking holds that environmental estrogens cause
endocrine disruption when these steroid mimics enter the cell’s
nucleus and turn genes on or off, or up or down, by binding to
DNA. According to this genomic–nuclear pathway model, many
xenoestrogens are viewed as harmless to humans and wildlife because
exposure to high levels of chemical is necessary before there is a
change in gene expression. However, the genomic model assumes a
long, multistep process of macromolecular synthesis; it does not fully
account for empirical evidence that the signal response to some hor-
mones is so fast it must be initiated outside the cell via membrane
receptors connected to fast-acting molecules. An alternative mem-
brane-initiated hypothesis is just beginning to be addressed and test-
ed. This month, Nataliya N. Bulayeva and Cheryl S. Watson of the
University of Texas Medical Branch report experimental evidence
that challenges the prevailing genomic paradigm of endocrine dis-
ruption [EHP 112:1481–1487].
For their experiments, the scientists employed a prolactinoma
cell line derived from a rat pituitary gland that has been a model
experimental cell line for over 30 years. A subline of these cells that
exhibits fast responses and is sensitive to estrogens at small doses pro-
vides a good test system for the study of nongenomic responses to
estrogenic compounds. This system allows researchers to investigate
questions about mechanisms by measuring functional end points of
estrogen action, such as prolactin secretion, which increases upon
exposure to estrogen. 
Extracellular signal–regulated protein kinases, or ERKs, belong to
a large class of enzymes involved in cell signaling pathways that gener-
ate signals to multiple end points. They are good indicators of non-
genomic estrogenic activity because ERK activation is mediated by
phosphorylation, a signal from outside the cell. When ERKs are acti-
vated by exposure to estrogens or compounds that mimic estrogens,
the cell’s medium turns yellow. The yellow product, which correlates
with the amount of phosphorylated ERK identified by an antibody,
can be measured so precisely that small changes in levels of phospho-
rylated ERK can be detected. 
Bulayeva and Watson compared ERK activation by the most
potent endogenous estrogen—estradiol—with activation by three
major classes of xenoestrogens: organochlorine pesticides (endosul-
fan, dieldrin, and DDE, a DDT metabolite), detergents used in
plastics manufacturing (p-nonylphenol and bisphenol A), and
coumestrol (a phytoestrogen present in alfalfa sprouts, soybeans, and
sunflower seeds/oil). The responses were measured at different con-
centrations over a 3- to 30-minute time course. Affected points
along the activation pathway were subsequently investigated by the
addition of specific inhibitors to each pathway participant. 
The results showed that every xenoestrogen tested, except bisphe-
nol A, exhibited strong ERK activation. Unexpectedly, individual
compounds produced the effect at different times and concentrations
specific to the particular compounds. Also, individual compounds
were found to trigger specific pathways within the nongenomic signal-
ing network leading to different end points. Coumestrol, endosulfan,
and p-nonylphenol had an effect at extremely low picomolar levels, as
low as estradiol. The authors concluded, “These very low effective
doses for xenoestrogens demonstrate that many environmental conta-
mination levels previously thought to be subtoxic may very well exert
significant signal- and endocrine-disruptive effects, discernable only
when the appropriate mechanism is assayed.” 
This study sheds new light on the conundrum of why exposure
to concentrations of environmental estrogens deemed safe by the
genomic model exhibit well-documented harmful effects on wildlife.
It raises new concerns about the effect of xenoestrogens on human
health and important questions about the adequacy of current envi-
ronmental protection policy and regulations based on the genomic
model. –Mary Eubanks
New model explains differences. Researchers compared ERK activa-
tion by three classes of environmental estrogens found in pesticides,
plastics, and plants to that of estradiol. Results showed that, unlike pre-
viously believed, not all xenoestrogens act the same.